Literature DB >> 8806547

Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha.

C A Smith1, F Q Hu, T D Smith, C L Richards, P Smolak, R G Goodwin, D J Pickup.   

Abstract

We show the cowpox genome (Brighton Red strain) contains a single copy gene, crmC, expressed at late times during viral infection, encoding a soluble, secreted protein whose sequence marks it as a new member of the TNF receptor family. The cysteine-rich protein contains 186 amino acids, the N-terminal 21 of which constitute a signal peptide, and two potential N-linked glycosylation sites. The approximately 25-kDa recombinant protein binds TNF specifically and completely inhibits TNF-mediated cytolysis. The strongest sequence homologues are the ligand-binding regions of the type II cellular TNF receptor (TNFRII) and CrmB, a distinct pox virus gene also encoding a soluble TNF binding protein. Unlike TNFRII and CrmB, CrmC does not bind lymphotoxin (LT alpha, TNF beta) and lacks the conserved (but nonhomologous) approximately 150-residue C-terminal domain of CrmB proteins. The presumed function of CrmC is viral inhibition of host-elicited TNF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806547     DOI: 10.1006/viro.1996.0462

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

1.  CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.

Authors:  M Saraiva; A Alcami
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis.

Authors:  J Bertin; R C Armstrong; S Ottilie; D A Martin; Y Wang; S Banks; G H Wang; T G Senkevich; E S Alnemri; B Moss; M J Lenardo; K J Tomaselli; J I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  A secreted high-affinity inhibitor of human TNF from Tanapox virus.

Authors:  Craig R Brunetti; Mini Paulose-Murphy; Rajkumari Singh; Jing Qin; John W Barrett; Aubry Tardivel; Pascal Schneider; Karim Essani; Grant McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

Review 4.  Diverse mechanisms evolved by DNA viruses to inhibit early host defenses.

Authors:  Marni S Crow; Krystal K Lum; Xinlei Sheng; Bokai Song; Ileana M Cristea
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

5.  Comparative Biochemical and Functional Analysis of Viral and Human Secreted Tumor Necrosis Factor (TNF) Decoy Receptors.

Authors:  Sergio M Pontejo; Ali Alejo; Antonio Alcami
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

6.  A tumour necrosis factor receptor-like protein encoded by Singapore grouper iridovirus modulates cell proliferation, apoptosis and viral replication.

Authors:  Yepin Yu; Youhua Huang; Shina Wei; Pengfei Li; Lingli Zhou; Songwei Ni; Xiaohong Huang; Qiwei Qin
Journal:  J Gen Virol       Date:  2015-12-21       Impact factor: 3.891

7.  Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates.

Authors:  N S Lurain; K S Kapell; D D Huang; J A Short; J Paintsil; E Winkfield; C A Benedict; C F Ware; J W Bremer
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function.

Authors:  Shu-Jung Chang; Jye-Chian Hsiao; Stephanie Sonnberg; Cheng-Ting Chiang; Min-Hsiang Yang; Der-Lii Tzou; Andrew A Mercer; Wen Chang
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 9.  Subversion of cytokine networks by virally encoded decoy receptors.

Authors:  Megan L Epperson; Chung A Lee; Daved H Fremont
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

10.  Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.

Authors:  Zoe Waibler; Martina Anzaghe; Holger Ludwig; Shizuo Akira; Siegfried Weiss; Gerd Sutter; Ulrich Kalinke
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.